Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.
Tokunaga M, Yonekura K, Nakamura D, Haraguchi K, Tabuchi T, Fujino S, Hayashida M, Maekawa K, Arai A, Nakano N, Kamada Y, Kubota A, Inoue H, Owatari S, Takeuchi S, Takatsuka Y, Otsuka M, Hanada S, Matsumoto T, Yoshimitsu M, Ishitsuka K, Utsunomiya A.
Tokunaga M, et al. Among authors: owatari s.
Br J Haematol. 2018 May;181(4):539-542. doi: 10.1111/bjh.14634. Epub 2017 Apr 3.
Br J Haematol. 2018.
PMID: 28369823
Free article.
No abstract available.